Evidence map›Paper›PMID 41992276›Full record

ArticleRespiratory research2026

Increasing propellant gas emissions from pressurized metered-dose inhalers in obstructive lung diseases in France over 11 years.

Jade Mahé, Grégoire Muller, Nicolas Roche, Arnaud Bourdin, David Grimaldi, Maxime Patout, Maéva Zysman

Abstract read
In one paragraph

Article in Respiratory research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jade Mahé *Service des Maladies Respiratoires, CHU Bordeaux, Pessac, 33604, France. jade.mahe33@gmail.com.
Grégoire Muller *Service de Médecine Intensive Réanimation, Centre Hospitalier Universitaire (CHU) d'Orléans, Orléans, France.
Nicolas RocheService de Pneumologie, Hôpital Cochin, AP-HP centre, 27, rue du Faubourg Saint-Jacques, Paris, 75014, France.
Arnaud BourdinDépartement de Pneumologie et Addictologie ; PhyMedExp, University of Montpellier, INSERM U1046, CNRS UMR 9214, Hôpital Arnaud de Villeneuve CHU Montpellier, Montpellier, France.
David GrimaldiThe Shift Project, Paris, France.
Maxime Patout *Service des Pathologies du Sommeil, Groupe Universitaire Hospitalier AP- HP - Sorbonne Université, Paris, France.
Maéva Zysman *Service des Maladies Respiratoires, CHU Bordeaux, Pessac, 33604, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionManagement of chronic obstructive respiratory diseases involves the use of inhaled therapies, including pressurized metered-dose inhalers (pMDIs) that contain hydrofluoroalkane (HFA). These propellant gases contribute to greenhouse gas emissions (GHG) due to their infrared radiation absorption capacity, resulting in a high Global Warming Potential, far higher than carbon dioxide (CO

methodsData were extracted from the French Health System Open Medic Database, covering 2014 to 2024. Gas quantities were obtained from the French Theriaque Database and, when unavailable, from pharmaceutical companies. Emissions were expressed as CO

resultsOver the past decade, 500 million inhalers were dispensed, pressurized metered-dose inhalers representing 44% of them. Gas quantity data was available for 83% of the units. Over the 11-year period, total emissions reached 4.5 million MtCO DISCUSSION: This exhaustive national study shows that pressurized metered-dose inhalers emitted more than 4,5 MtCO

Indexed as

Aerosol PropellantsCarbon FootprintHydrocarbons, FluorinatedLung Diseases, ObstructiveMetered Dose InhalersPulmonary Disease, Chronic ObstructiveFluorocarbonsFranceHumansTime FactorsAerosol PropellantsFluorocarbonsHydrocarbons, FluorinatedAlternate therapiesChronic obstructive pulmonary diseaseCO2 equivalentGreenhouse gasPressurized metereddose inhalers

Identifiers

PMID41992276
PMCPMC13085310

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.